Albion Financial Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-36,840
Closed -$7.55M 199
2017
Q3
$7.55M Buy
36,840
+3,901
+12% +$907K 1.15% 27
2017
Q2
$8.01M Sell
32,939
-59
-0.2% -$13.9K 1.33% 26
2017
Q1
$7.88M Sell
32,998
-19,281
-37% -$4.49M 1.18% 27
2016
Q4
$11M Sell
52,279
-7,093
-12% -$1.47M 1.82% 12
2016
Q3
$13.7M Sell
59,372
-70,270
-54% -$17.2M 2.34% 4
2016
Q2
$30M Sell
129,642
-1,974
-1% -$455K 5.38% 3
2016
Q1
$35.3M Buy
131,616
+41,725
+46% +$11.9M 5.99% 3
2015
Q4
$28.1M Sell
89,891
-25,545
-22% -$7.61M 4.83% 3
2015
Q3
$31.4M Sell
115,436
-811
-0.7% -$249K 5.68% 3
2015
Q2
$35.3M Sell
116,247
-264
-0.2% -$78.7K 5.86% 3
2015
Q1
$34.7M Sell
116,511
-2,398
-2% -$684K 5.89% 3
2014
Q4
$30.6M Sell
118,909
-634
-0.5% -$158K 5.29% 3
2014
Q3
$28.8M Buy
119,543
+827
+0.7% +$185K 5.11% 3
2014
Q2
$26.5M Buy
118,716
+2,588
+2% +$536K 4.59% 3
2014
Q1
$23.9M Buy
116,128
+956
+0.8% +$189K 4.41% 3
2013
Q4
$19.3M Buy
115,172
+4,574
+4% +$715K 3.63% 3
2013
Q3
$15.9M Buy
110,598
+322
+0.3% +$42.9K 3.4% 4
2013
Q2
$13.9M Buy
+110,276
New +$12.5M 3.09% 3

Other funds holding AGN

Albion Financial Group's AGN Position: Q4 2017 in Review

Albion Financial Group sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 36,840 shares — an estimated $7.55M sold.

Albion Financial Group first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $35.3M in Q1 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Albion Financial Group reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Albion Financial Group sold 36,840 Allergan plc shares in Q4 2017, an estimated $7.55M.
  • Albion Financial Group first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
  • Albion Financial Group's Allergan plc position peaked at $35.3M in Q1 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Albion Financial Group's 13F filing for Q4 2017, filed 22 Feb 2018.